Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients - A case controlled study from india

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 3, 2009, Pages 581-592

  Kumar, Arun ^a   Nagtilak, Suryakant ^b   Sivakanesan, Ramiah ^c   Gunasekera, Susil ^c  

^a MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

^b Saraswati Institute of Medical Sciences and Research   (India)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HEART INFARCTION; HUMAN; INDIA; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; WAIST HIP RATIO;

AGED; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 67650179142     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Auxter S. Cardiac ischemia testing: a new era in chest pain evaluation. Clin Lab News 2003; 29: 1-3.
2. Aulinskas TH, Vander Westhuyzen DR. Coetzee GA. Ascorbate increases the number of low density lipoprotein receptors in cultured arterial smooth muscle cells. Atherosclerosis 1983;47:159-71.
3. Aviram M., Rosenblat M., Billecke S., Eroul J., Sovenson R., Bisaier CL. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radio Biol Med 1999; 26: 892-904.
4. Awadallah SM, Hamad M., Jbarah I., Salem NM, Mubarak MS. Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease. Clin Chim Acta 2006; 365: 330-6.
5. Ayub A., Mackness MI, Sharon A., Mackness B., Patel J., Durrington PN. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 330-5.
6. Azizi F., Rahmani M., Raiszadeh F., Solati M., Navab M. Associations of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease. Coron Artery Dis 2002; 13:9-16.
7. Balarajan R. Ethnicity and variations in mortality from coronary heart disease. Health Trends 1996; 28: 45-51.
8. Bar-Or, D., Lau E., Rao N., Bampos N., Winkler JV, Curtis CG. Reduction in the cobalt binding capacity of human albumin with myocardial ischemia. Ann Emerg Med 1999; 34: 556.
9. Berliner JA, Navab M., Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-96.
10. Bernheim S., Bernheim MLC, Wilbur KM. The reaction between thiobarbituric acid and the oxidant product of certain lipids. J Biol Chem 1948; 174: 257-64.
11. Berton G., Cordiano R., Palmieri R., Pianca S., Pagliara V., Palatini P. C-Reactive protein in acute myocardial infarction: association with heart failure. Am Heart J 2003; 145:1094-101.
12. rd ed. New York: Grune and Stratton, 1984: 105.
13. Beg M., Nizami A., Singhal KC, Mohammed J., Gupta A., Azfar SF. Role of serum fibrinogen in patients of ischemic cerebrovascular disease. Nepal Med Coll J 2007; 9: 88-92.
14. Bhagat S., Gaiha M., Sharma VK, Anuradha SA. Comparative evaluation of C - reactive protein as a short-term prognostic marker in severe unstable angina- a preliminary study. J Assoc Physicians 2003; 51: 349-54.
15. Bhakuni P., Chandra M., Misra MK. Levels of free radical scavengers and antioxidants in post perfused patients of myocardial infarction. Curr Sci 2005a; 89: 168-70.
16. Bhakuni P., Chandra M., Misra MK. Oxidative stress parameters in erythrocytes of postreperfused patients with myocardial infarction. J Enzyme Inhib Med Chem 2005b; 20:337-81.
17. Boncler M., Luzak B., Watala C. Role of C-reactive protein in atherogenesis. Postepy Hig Med Dosw 2006; 60: 538-46.
18. Brand FN, Mcgee DL, Kannel WB, Stokes J., Castelli W. P. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121: 11-8.
19. Brown H. The determination of uric acid in human blood. J Biol Chem 1945; 158: 601-8.
20. Bulatao RAO, Stephens PW. Demographic estimates and projections, by region, 1970-2015. In: Jamison DT, Mosley WH, eds. Disease control priorities in developing countries. Washington, DC: World Bank, 1990 Health sector priorities review no. 13.)
21. Burman A., Jain K., Gulati R., Chopra V., Agrawal DP, Vaisisht S. Lipoprotein (a) as a marker of coronary artery disease and its association with dietary fat. J Assoc Physicians India 2004; 52: 99-102.
22. Chawla R., Goyal N., Calton R., Goyal S. Ischemia modified albumin: A novel marker for acute coronary syndrome. Indian J Clin Biochem 2006; 21: 77-82.
23. Chopra V., Wasir H. Implications of lipoprotein abnormalities in Indian patients. J Assoc Physicians India 1998; 46: 814-8.
24. Coppola G., Rizzo M., Maurizio GA, et al. Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow up study. Ital Heart J 2005; 6: 315-22.
25. Das S., Yadav D., Narang R., Das N. Interrelationship between lipid peroxidation, ascorbic acid and superoxide dismutase in coronary artery disease. Curr Sci 2002; 83: 488-91.
26. Djousse L., Rothman KJ, Cupples LA, Levy D., Ellison RC. Effect of serum albumin and bilirubin as a risk factor for myocardial infarction. Am J Cardiol 2003; 91: 485-8.
27. El- Badry I., Abon El N., Yehia TK, Zakhari MM. Free radicals activity in acute myocardial infarction. Egypt Heart J 1995; 47: 71-8.
28. Frei B., Stacker R., Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1998; 85: 9748-52.
29. Ghosh J., Mishra TK, Rao YN, Aggarwal SK. Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease. Indian J Clin Biochem 2006; 21: 181-4.
30. Giurgie N., Constantinescu MI, Stanciu R., Suciu S., Muresan A. Ceruloplasmin- acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease. Med Sci Monit 2005; 11: RA 48-51.
31. Gomez MA, Anderson JL, Karagounis LA, Muhlestein JB, Mooers FB. An emergency medicine based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense. Results of randomized study (ROMO). J Am Coll Cardiol 1996; 28: 25-33.
32. Goswami K., Bandyopadhyay. Lipid profile in middle class Bengali population of Kolkata. Ind J Clin Biochem 2003; 18: 127-30.
33. Gupta M., Chari S. Proxidant and antioxidant status in patients of type II diabetes mellitus with IHD. Indian J Clin Biochem 2006; 21:118-22.
34. Harkut PV, Sahashrabhojney VS, Salkar RG. Plasma fibrinogen as a marker of major adverse cardiac events in patients of type 2 diabetes with unstable angina. Int J Diab Dev Count 2004; 24: 69-74.
35. Heitman BL, Frederickson P., Lissner L. Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res 2004;12:482-7.
36. Jarvik GP, Tsai NT, Mckinstry LA, et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002; 22: 1329.
37. Jendrassik L., Grof B. Vereinfachte photometrische bestimmung des bilirubins. Biochem Z 1938; 297: 81-9. [in German]
38. Jing F., Alderman MH. Serum uric acid and cardiovascular mortality. JAMA 2000; 283:2404-10.
39. Kharb S. Low glutathione levels in acute myocardial infarction. Indian J Med Sci 2003; 57: 335-7.
40. Kurl S., Tuomainen TP, Laukkanen JA, et al. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 2002; 33:1568.
41. Kulsoom B., Nazrul SH. Association of serum C - reactive protein and LDL: HDL with myocardial infarction. J Pak Med Assoc 2006; 56: 318-22.
42. Kumar A., Sivakanesan R. Does plasma fibrinogens and C-reactive protein predict the incidence of myocardial infarction in patients with normal lipids profile? Pak J Med Sci 2008; 24: 336-9.
43. Libby P. Vascular biology of atherosclerosis: Overview and state of art. Am J Cardiol 2003; 91 (suppl) : 3A-6A.
44. Malhotra P., Kumari S., Singh S., Verma S. Isolated lipid abnormalities in rural and urban normotensive and hypertensive north-west Indians. J Assoc Physicians India 2003; 51: 459-63.
45. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
46. Megnien JL, Denarie N., Cocaul M. Predicitve value of waist-to-hip ratio on cardiovascular risk events. Int J Obes Relat Metab Disord 1999; 23: 90-7.
47. Mishra A., Luthra K., Vikram NK. Dyspipidemia in Asian Indians: determminants and significance. J Assoc Physicians India 2005; 52: 137-42.
48. Mishra TK, Routray SN, Patnaik UK, Padhi PK, Satapathy C., Behera M. Lipoprotein (a) and lipid profile in young patients with angiographically proven coronary artery disease. Indian Heart J 2001; 53: (5) article no. 60.
49. Nascetti S., D' Addato S., Pascarelli N., Sangiorgi Z., Grippo MC, Gaddi A. Cardiovascular disease and Lp (a) in the adult population and in the elderly: the Brisighella study. Riv Eur Sci Med Farmacol 1996; 18: 205-12.
50. Niskanen LK, Laaksonen DE, Nyyssonen K., et al. Uric acid level as a risk factor for cardiovascular and all- cause moratlity in middleaged men: a prospective study. Arch Intern Med 2004; 164: 1546-51.
51. Nyyssonen K., Markku TP, Salonen R., Tuomilehto J., Salonen]T. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997; 314: 634.
52. Olusi SO, Prabha K., Sugathan TN. Biochemical risk factors for myocardial infarction among South Asian immigrants and Arabs. Ann Saudi Med 1999; 19: 147-9.
53. Paglia DE, Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
54. Patil N., Chavan V., Karnik ND. Antioxidant status in patients with acute myocardial infarction. Indian J Clin Biochem 2007; 22: 45-51.
55. Pepys MB, Hirschfield G. M. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-12. doi: 10.1172/JCI200318921.
56. Perry BW, Doumas BT. Effect of heparin on albumin determination by use of bromocresol green and bromocresol purple. Clin Chem 1979; 25:1520-2.
57. Rajasekhar D., Srinivasa Rao PV, Latheef SA, Saibaba KS, Subramanyam G. Association of serum antioxidants and risk of coronary heart disease in South Indian population. Indian J Med Sci 2004; 58: 465-71.
58. Rani SH, Madhavi G., Ramachandra RV, Sahay BK, Jyothy A. Risk factors for coronary heart disease in type II diabetes. Indian J Clin Biochem 2005; 20: 75-80.
59. Ravin HA. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Med 1961; 58: 161-8.
60. Recknagel RO, Glende EA. Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 1984; 105: 331-7.
61. Reddy KS. Cardiovascular disease in India. World Health Stat Q 1993; 46: 101-7.
62. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601.
63. Richard JW, Leview I., Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000; 101: 2252.
64. Roe JH, Kuether CA. The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 1943; 147: 399.
65. Sarkar PD, Shivaprakash TM, Madhusudhan B. Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease. Clin Chim Acta 2006; 373: 77-81.
66. Senthil S., Veerappan RM, Ramakrishna RM, Pugalendi KV. Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clin Chim Acta 2004; 348: 131-7.
67. Shrinivas K., Vijaya Bhaskar M., Aruna Kumari M., Nagaraj K., Reddy KK. Antioxidants, lipid peroxidation and lipoproteins in primary hypertension. Indian Heart J 2000; 52: 285-8.
68. Shinde S., Kumar P., Patil N. Decreased levels of erythrocyte glutathione in patients with myocardial infarction. Internet J Alternat Med 2005; 2:1.
69. Shukla N., Maher J., Masters J., Angelini GD, Jeremy JY. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis 2006; 187: 238-50.
70. Singh S., Venketesh S., Verma JS, Verma M., Lellamma CO, Goel RC. Paraoxonase (PON11) activity in northwest Indian Punjabis with coronary artery disease and type II diabetes mellitus. Indian J Med Res 2007; 125: 783-7.
71. Sivaraman S K., Zachariah G., Annamalai PT. Evaluation of C - reactive protein and other Inflammatory markers in acute coronary syndromes. Kuwait Med J 2004; 36: 35-7.
72. Sun Y., Oberly LW, Li Y. A. simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
73. Vasisht S., Narula J., Awtade A., Tandon R., Srivastava LM. Lipids and lipoproteins in normal controls and clinically documented coronary heart disease patients. Ann Natl Acad Med Sci (India) 1990; 26: 57-66.
74. Yadhav AS, Bhagwat VR, Rathod IM. Relationship of plasma homocysteine with lipid profile parameters in ischemic heart disease. Indian J Clin Biochem 2006; 21: 106-10.